BDNF and Parkinson disease: Apigenin and luteolin both in combination rescue the dopaminergic neurons through reducing microglial activation, neuroinflammation, oxidative stress as well as enhancement of BDNF in MPTP induced mice model of PD. The study suggested that both the molecules could be potential therapeutics in PD.